학술논문
First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,
Document Type
Abstract
Author
d'Amore, Francesco; da Silva, Maria Gomes ; Leppa, Sirpa; Relander, Thomas ; Pezzutto, Antonio ; Lauritzsen, Grete F. ; Weidmann, Eckhart ; Van Gelder, Michel; Merup, Mats ; Hagberg, Hans ; Fagerli, Unn-Merete ; Brown, Peter de Nully ; Hansen, Per Boye ; Mariz, Jose Mario ; Jankovska, Milada ; Walewski, Jan; Doorduijn, Jeanette ; Van Hoof, Achiel; Christiansen, Ilse; Jyrkkiö, Sirkku ; Kluin-Nelemans, J.C.; van Marwijk Kooy, Marinus ; Fijnheer, Rob ; Stevens, Wendy ; Zijlstra, Josee ; Böhmer, L. ; Lugtenburg, P.J.; Grube, Matthias ; Prochazka, Vit ; Salek, David ; Greil, Richard; Trümper, Lorenz ; Wulf, Gerald; Altmann, Bettina ; Ziepert, Marita ; Loeffler, Markus ; Jantunen, Esa ; Hopfinger, Georg ; Neste, Eric Van den ; Toldbod, Helle
Source
In Blood 18 November 2011 118(21):4110-4110
Subject
Language
ISSN
0006-4971